UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,832
-100.0%
59,839
-73.3%
0.70%
-96.8%
Q2 2021$28,881,000
+60.8%
224,391
+0.0%
22.15%
+110.2%
Q1 2021$17,960,000224,39010.54%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders